Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
EMvision Medical Devices Ltd. ( (AU:EMV) ) has issued an announcement.
EMVision Medical Devices Ltd. successfully completed an oversubscribed Share Purchase Plan (SPP), raising $2.0 million and issuing over a million new shares and options. This, combined with a recent $12.0 million placement, strengthens the company’s financial position to advance key milestones such as pivotal trial readouts, FDA submissions, and commercialization of their emu device, as well as progress in the First Responder program. The high demand led to a scale-back of applications, ensuring equitable allocation among shareholders.
The most recent analyst rating on (AU:EMV) stock is a Hold with a A$2.00 price target. To see the full list of analyst forecasts on EMvision Medical Devices Ltd. stock, see the AU:EMV Stock Forecast page.
More about EMvision Medical Devices Ltd.
EMVision Medical Devices Limited is an Australian company specializing in innovative medical devices. The company focuses on developing portable, non-invasive, and affordable neurodiagnostic devices aimed at improving the diagnosis and treatment of stroke and other time-sensitive medical emergencies at the point-of-care.
Average Trading Volume: 84,772
Technical Sentiment Signal: Sell
Current Market Cap: A$162.2M
Find detailed analytics on EMV stock on TipRanks’ Stock Analysis page.